The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistanceAnastasia C. Hepburn(Newcastle University), Rakesh Heer(Newcastle upon Tyne Hospitals NHS Foundation Trust)OncogeneFebruary 11, 201910.1038/s41388-019-0712-yCited by 94SaveCiteExport RISWatch citationsRelated PapersSide Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling|PLoS ONE|2012|48